Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Recruiting now
Conditions studied: Adult Congenital Heart Disease, Congenital Heart Disease, Systemic Right Ventricle, Transposition of the Great Arteries, Congenitally Corrected Transposition of the Great Arteries, Fontan, Single Ventricle, Tetralogy of Fallot (TOF)
In brief
This real-world, international registry aims to evaluate the current experience with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease (ACHD) patients by investigating the prescription patterns, safety, tolerability, and potential beneficial effects on heart failure-related outcomes.
Key facts
- Study ID
- NCT06932081
- Run by
- Leiden University Medical Center
- People needed
- 400
- Starts
- 2023-01-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-02-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Congenital heart defect.
- Age ≥ 18 years.
- Initiated on treatment with an SGLT2i.
You may not qualify if…
- No consent for data collection.
Where it is running
- Johns Hopkins University — Baltimore, Maryland, United States (enrolling)
- Helen DeVos Children's Hospital — Grand Rapids, Michigan, United States (enrolling)
- Mount Sinai Fuster Heart Hospital — New York, New York, United States (enrolling)
- Heart Center Duisburg (Evangelical Hospital Niederrhein) — Duisburg, Germany (enrolling)
- Leiden University Medical Center (LUMC) — Leiden, South Holland, Netherlands (enrolling)
- Amsterdam University Medical Center — Amsterdam, Netherlands (enrolling)
- University Medical Center Utrecht — Utrecht, Netherlands (enrolling)
- Zan Mitrev Clinic — Skopje, North Macedonia (enrolling)
- University Hospital of Wales — Cardiff, United Kingdom (enrolling)
- Golden Jubilee University National Hospital — Glasgow, United Kingdom (enrolling)
- Barts Heart Centre — London, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.